Healthcare -
Biotechnology - NASDAQ - US
$ 0.6438
-3.06 %
$ 81.2 M
Market Cap
-0.61
P/E
KPTI - OPERATING INCOME
Operating Income KPTI - Karyopharm Therapeutics Inc.
-130 M
LAST VALUE
-14.81%
2 YEAR CAGR
6.36%
5 YEAR CAGR
-14.33%
10 YEAR CAGR